FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019921670> ?p ?o ?g. }

• W2019921670 endingPage "1324" @default.
• W2019921670 startingPage "1313" @default.
• W2019921670 abstract "We have shown previously that in addition to IL-4, IL-5 and IL-10, antigen-specific interferon-γ (IFN-γ) production by spleen cells from ovalbumin (OVA)/Alum-immunized mice is inhibited by the administration of royal jelly (RJ). Since it has been shown that both Th1 and Th2 cytokines play pathogenic roles in the generation of atopic dermatitis (AD), we have examined whether RJ suppresses the development of AD-like skin lesions in NC/Nga mice induced by repeated application of picryl chloride (PiCl) under specific pathogen-free (SPF) conditions. Oral administration of RJ to the PiCl-treated NC/Nga mice inhibited the development of AD-like skin lesions in these mice as exemplified by the significant decrease in the total skin severity scores and the decrease in hypertrophy, hyperkeratosis, and infiltration of the epidermis and corium by inflammatory cells. IFN-γ production by spleen cells from PiCl-treated NC/Nga mice in response to TNP–KLH was partially but significantly inhibited by the oral administration of RJ, while IFN-γ production by Con A-stimulated spleen cells was not affected. Since inducible nitric oxide (NO) synthase (iNOS)-derived NO has been suggested as an important immunoregulatory mediator in inflammatory autoimmune diseases, we have also examined the expression of iNOS in the dorsal skin lesions of PiCl-treated NC/Nga mice. Interestingly, the expression of iNOS was significantly increased in the skin lesions of RJ-administered mice compared with those of control PBS-administered mice. Thus, our results suggest that RJ suppresses the development of AD-like skin lesions in PiCl-treated NC/Nga mice, possibly by a combination of down-regulating TNP-specific IFN-γ production and up-regulating iNOS expression." @default.
• W2019921670 created "2016-06-24" @default.
• W2019921670 creator A5006850931 @default.
• W2019921670 creator A5019488016 @default.
• W2019921670 creator A5027748129 @default.
• W2019921670 creator A5030372272 @default.
• W2019921670 creator A5035096594 @default.
• W2019921670 creator A5039053175 @default.
• W2019921670 creator A5050132111 @default.
• W2019921670 creator A5057283487 @default.
• W2019921670 creator A5078804188 @default.
• W2019921670 date "2003-09-01" @default.
• W2019921670 modified "2023-10-18" @default.
• W2019921670 title "Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice" @default.
• W2019921670 cites W1543202257 @default.
• W2019921670 cites W1546445911 @default.
• W2019921670 cites W1606476961 @default.
• W2019921670 cites W1646743268 @default.
• W2019921670 cites W1970140945 @default.
• W2019921670 cites W1991195369 @default.
• W2019921670 cites W1991484350 @default.
• W2019921670 cites W1997033326 @default.
• W2019921670 cites W2001416665 @default.
• W2019921670 cites W2003080015 @default.
• W2019921670 cites W2003293386 @default.
• W2019921670 cites W2007650463 @default.
• W2019921670 cites W2014592293 @default.
• W2019921670 cites W2015776844 @default.
• W2019921670 cites W2015941743 @default.
• W2019921670 cites W2022587490 @default.
• W2019921670 cites W2029491963 @default.
• W2019921670 cites W2038682607 @default.
• W2019921670 cites W2045024700 @default.
• W2019921670 cites W2047976786 @default.
• W2019921670 cites W2062093468 @default.
• W2019921670 cites W2071374363 @default.
• W2019921670 cites W2079282933 @default.
• W2019921670 cites W2086594222 @default.
• W2019921670 cites W2101237312 @default.
• W2019921670 cites W2103229419 @default.
• W2019921670 cites W2113127336 @default.
• W2019921670 cites W2137722996 @default.
• W2019921670 cites W2145110135 @default.
• W2019921670 cites W2146872665 @default.
• W2019921670 cites W2154376533 @default.
• W2019921670 cites W2159837806 @default.
• W2019921670 cites W2312870247 @default.
• W2019921670 cites W4239986690 @default.
• W2019921670 doi "https://doi.org/10.1016/s1567-5769(03)00132-2" @default.
• W2019921670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12890429" @default.
• W2019921670 hasPublicationYear "2003" @default.
• W2019921670 type Work @default.
• W2019921670 sameAs 2019921670 @default.
• W2019921670 citedByCount "94" @default.
• W2019921670 countsByYear W20199216702012 @default.
• W2019921670 countsByYear W20199216702013 @default.
• W2019921670 countsByYear W20199216702014 @default.
• W2019921670 countsByYear W20199216702015 @default.
• W2019921670 countsByYear W20199216702016 @default.
• W2019921670 countsByYear W20199216702017 @default.
• W2019921670 countsByYear W20199216702018 @default.
• W2019921670 countsByYear W20199216702020 @default.
• W2019921670 countsByYear W20199216702021 @default.
• W2019921670 countsByYear W20199216702022 @default.
• W2019921670 countsByYear W20199216702023 @default.
• W2019921670 crossrefType "journal-article" @default.
• W2019921670 hasAuthorship W2019921670A5006850931 @default.
• W2019921670 hasAuthorship W2019921670A5019488016 @default.
• W2019921670 hasAuthorship W2019921670A5027748129 @default.
• W2019921670 hasAuthorship W2019921670A5030372272 @default.
• W2019921670 hasAuthorship W2019921670A5035096594 @default.
• W2019921670 hasAuthorship W2019921670A5039053175 @default.
• W2019921670 hasAuthorship W2019921670A5050132111 @default.
• W2019921670 hasAuthorship W2019921670A5057283487 @default.
• W2019921670 hasAuthorship W2019921670A5078804188 @default.
• W2019921670 hasConcept C134018914 @default.
• W2019921670 hasConcept C164027704 @default.
• W2019921670 hasConcept C203014093 @default.
• W2019921670 hasConcept C2776914184 @default.
• W2019921670 hasConcept C2776946954 @default.
• W2019921670 hasConcept C2777056448 @default.
• W2019921670 hasConcept C2778329239 @default.
• W2019921670 hasConcept C2778786243 @default.
• W2019921670 hasConcept C2780931953 @default.
• W2019921670 hasConcept C71924100 @default.
• W2019921670 hasConcept C8891405 @default.
• W2019921670 hasConcept C98274493 @default.
• W2019921670 hasConceptScore W2019921670C134018914 @default.
• W2019921670 hasConceptScore W2019921670C164027704 @default.
• W2019921670 hasConceptScore W2019921670C203014093 @default.
• W2019921670 hasConceptScore W2019921670C2776914184 @default.
• W2019921670 hasConceptScore W2019921670C2776946954 @default.
• W2019921670 hasConceptScore W2019921670C2777056448 @default.
• W2019921670 hasConceptScore W2019921670C2778329239 @default.
• W2019921670 hasConceptScore W2019921670C2778786243 @default.
• W2019921670 hasConceptScore W2019921670C2780931953 @default.
• W2019921670 hasConceptScore W2019921670C71924100 @default.
• W2019921670 hasConceptScore W2019921670C8891405 @default.

• next